Chesapeake PERL

Chesapeake PERL, Inc., also known as C-PERL Bio, is a biotechnology company headquartered in Savage, Maryland. The company is a privately held entity with 5 employees and generates an annual revenue of $8.6 million. C-PERL Bio specializes in developing recombinant proteins for a variety of applications, including product discovery, research, and marketing. Their protein offerings encompass a wide range, including monoclonal antibodies, virus antigens, receptor molecules, and specialty enzymes, all produced using insect cells and insect larvae. In addition to proteins, the company also provides insect products derived from species such as cabbage looper, corn earworm, tobacco budworm, fall armyworm, beet armyworm, and diamondback moth. C-PERL Bio distinguishes itself through its expertise in recombinant protein production utilizing insect-based systems. This unique approach allows for the creation of high-quality proteins tailored for specific research and development needs. For further information or inquiries, please visit Chesapeake PERL, Inc.'s website at c-perl.com.